| Jul 11 |
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
|
| Jul 10 |
Glaukos cut as Citi reviews U.S. MedTechs ahead of Q2 results
|
| Jul 10 |
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
|
| Jul 10 |
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
|
| Jul 8 |
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
|
| Jun 27 |
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
|
| Jun 27 |
Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?
|
| Jun 14 |
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
|
| Jun 6 |
Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?
|
| Jun 5 |
Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?
|
